Results 51 to 60 of about 4,127 (170)

Safety and Efficacy of Combined Yttrium 90 Resin Radioembolization with Aflibercept and FOLFIRI in a Patient with Metastatic Colorectal Cancer

Case Reports in Oncological Medicine, 2015
Background. When associated with isolated four or fewer liver foci, metastatic colorectal cancer is amenable to surgical resection. Alternative therapeutic methods for isolated liver metastases include radioembolization with yttrium 90 (Y90) and ...
Andre De Souza, Kevin Pelham Daly, James Yoo, Muhammad Wasif Saif   +3 more
doaj   +1 more source

Hepatic Abscess following Yttrium-90 Radioembolization in Patients with Surgical Bilioenteric Anastomosis or Compromised Sphincter of Oddi: A Tertiary Cancer Center Experience

Current Oncology, 2022
Purpose: We describe our experience with the development of hepatobiliary infection in patients with prior surgical, percutaneous, or endoscopic biliary interventions who are receiving transarterial radioembolization (TARE) with yttrium-90 (90Y) for ...
Kevin N. Agahi, Armeen Mahvash, Mohamed E. Abdelsalam   +2 more
doaj   +1 more source

Visualized Clinical‐Radiomics Model Based on Non‐Contrast Computed Tomography for Predicting Efficacy of Surufatinib in Hepatic Metastases of Neuroendocrine Neoplasms

Cancer Medicine, Volume 15, Issue 5, May 2026.
NCCT radiomics for surufatinib efficacy prediction in HM‐NENs. ABSTRACT Background Hepatic metastatic neuroendocrine neoplasms (HM‐NENs) have few treatment biomarkers and low survival rates. We created a clinical‐radiomics fusion model based on non‐contrast computed tomography (NCCT) to predict Surufatinib efficacy in HM‐NENs.
Miaomiao Feng, Man Zhao, Xiaoling Duan, Jiaojiao Hou, Qi Wang, Fei Yin   +5 more
wiley   +1 more source

Influencing Factors of Lung Shunt Fraction in Transarterial Radioembolization Treatment

Clinical and Translational Imaging, 2023
Abstract Purpose We aimed to evaluate the influencing factors of lung shunt fraction(LSF) in patients who underwent transarterial radioembolization treatment. Methods We enrolled 105 patients who had either primary or metastatic liver disease.
Bilal Kovan, Caner Civan, Emine Goknur Isik, Duygu Has Simsek, Zeynep Gozde Ozkan, Fikret Buyukkaya, Yasemin Sanli, Bayram Demir, Serkan Kuyumcu   +8 more
openaire   +1 more source

Radioembolization Treatment for Liver Cancer

Bezmiâlem Science, 2016
Although curative treatment is surgery (resection/transplantation) and for small lesions ablative strategies, in primary liver carcinomas such as hepatocellular carcinoma and cholangiocellular carcinoma, palliative treatment is used for most of these ...
Ezgi Başak ERDOĞAN, Hüseyin ÖZDEMİR, Mehmet AYDIN   +2 more
doaj   +1 more source

Outcomes of Hepatocellular Carcinoma involving the Portal Vein Main Trunk and/or the Inferior Vena Cava: Experience From a Multidisciplinary Liver Cancer Clinic

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background Vascular invasion by hepatocellular carcinoma (HCC), particularly involving the main portal vein or inferior vena cava (IVC), is associated with poor prognosis. However, contemporary real‐world outcomes and the clinical benefit of liver‐directed therapies (LDT) in this setting are poorly defined.
I‐Chia Liu, Atif Zaheer, Chen Hu, Christopher Shubert, Kelly Lafaro, William R. Burns, Richard Burkhart, Jin He, Benjamin Philosophe, Jane Zorzi, Paige Griffith, Alexandra T. Strauss, Amy K. Kim, Robert Liddell, Kelvin Hong, Christos Georgiades, Robert Anders, Kiyoko Oshima, Elsa Hallab, Amol Narang, Won Jin Ho, Mark Yarchoan, Marina Baretti, Jeffrey Meyer   +23 more
wiley   +1 more source

New frontiers in radioembolization

Therapeutic Advances in Medical Oncology
Radioembolization is a locoregional transarterial therapy that combines radionuclide and micron-sized beads to deliver radiation internally to the target tumors based on the arterial blood flow. While initially developed as a palliative treatment option,
Arian Mansur, Peiman Habibollahi, Adam Fang, Armeen Mahvash, Vahid Etezadi, Robert P. Liddell, Juan C. Camacho, Emil I. Cohen, Nima Kokabi, Aravind Arepally, Christos Georgiades, Nariman Nezami   +11 more
doaj   +1 more source

Characterization of long‐term survivors with liver metastases from uveal melanoma diagnosed between 2005 and 2021

International Journal of Cancer, Volume 158, Issue 8, Page 2179-2185, 15 April 2026.
What's New? Liver metastasis is an indicator of life expectancy for patients with advanced uveal melanoma (UM). Data on anticipated survival time following the diagnosis of liver metastasis, however, is lacking. The present study analyzed long‐term survival among UM patients who lived three or more years after liver metastases were diagnosed.
Jona Laukhuf, Lisa Wiens, Gerd Grözinger, Helmut Dittmann, Karolin Thiel, Ulrike Leiter, Teresa Amaral, Lena Nanz, Lukas Flatz, Markus Reitmajer, Andrea Forschner   +10 more
wiley   +1 more source

Radioembolization for the treatment of hepatocellular carcinoma [PDF]

Clinical and Molecular Hepatology, 2017
Transarterial radioembolization (TARE) with yttrium 90 (90Y), an intra-arterial procedure performed by interventional radiologists, has begun being utilized in managing hepatocellular carcinoma (HCC) in Korea. There are two available TARE products: glass
Hyo-Cheol Kim
doaj   +1 more source

Flow-Directed Catheters in Hepatic Embolization Therapy—A Review with Clinical Cases

Journal of Clinical Interventional Radiology ISVIR, 2021
Transarterial embolization with chemotherapy and radiation is well-documented forms of treatment for liver cancers but reflux of embolic particles to nontarget tissues can result in unintended consequences such as gastrointestinal ulceration ...
Shams Iqbal, Lawrence Jordan Breyfogle, Sebastian Flacke   +2 more
doaj   +1 more source